1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United States >
  5. Mississippi >
  6. TA Associates Invests In Cypress Pharmaceutical

Investment Summary

TA Associates Invests In Cypress Pharmaceutical

On December 15, 2003, private equity firm TA Associates invested in life science company Cypress Pharmaceutical

Investment Highlights
  • This is TA Associates’ 4th transaction in the Life Science sector.
  • This is TA Associates’ 103rd transaction in the United States.
  • This is TA Associates’ 1st transaction in Mississippi.
Investment Fate
  • Cypress Pharmaceutical was sold to a strategic buyer in 2013.

Investment Summary
Date 2003-12-15
Target Cypress Pharmaceutical
Sector Life Science
Investor(s) TA Associates
Deal Type Stake Purchase

Target

Cypress Pharmaceutical

Madison, Mississippi, United States
Cypress Pharmaceutical is a rapidly growing specialty pharmaceutical company that develops, markets and distributes generic prescription, over-the-counter and specialty branded pharmaceutical products. Cypress provides generic and branded products to the leading national pharmaceutical wholesalers, chain drug stores, distributors and other retail merchandisers. Through its specialty branded business, Hawthorn Pharmaceuticals, the company also provides internally developed pharmaceutical products marketed directly to physician specialists.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

TA Associates

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1968
PE ASSETS 65.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TA Associates is a private equity firm that targets investments in middle-market and large companies around the world. TA will consider control or minority investments in profitable companies and looks to commit between $70 and $500 million per transaction. TA proactively reaches out to companies directly in sourcing potential investment opportunities. Prospective businesses are generally valued between $100 million and $3 billion. Areas of interest include technology, software, communications, financial services, healthcare, business services, semiconductors/electronics, and consumer products/services. In addition to investing equity capital, TA also makes subordinated debt investments. TA's geographic preference is North America, Asia/Pacific, and Europe. TA Associates was formed in 1968 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 110 of 374
Sector: Life Science M&A 4 of 11
Type: Stake Purchase M&A Deals 6 of 39
State: Mississippi M&A 1 of 1
Country: United States M&A 103 of 270
Year: 2003 M&A 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-12-09 Logistics Health

La Crosse, Wisconsin, United States

Logistics Health Inc. (LHI) is a rapidly growing provider of disease prevention and health information management services to the government and commercial enterprises. The company manages a national network of medical and dental providers that it uses to collect medical information. LHI also offers training services customized to prepare authorities to respond to disasters such as bio-terrorism.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-12-18 Tempur Sealy

Lexington, Kentucky, United States

Tempur Sealy is a bedding provider that develops, manufactures, and markets mattresses, foundations, pillows, and other products. Tempur Sealy was founded in 1989 and is based in Lexington, Kentucky.

Sell -
Mergr

Solution for

Product

Company

Legal